These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 7575995

  • 1. Analysis of action mechanism of lymphotoxin in prevention of cyclophosphamide-induced diabetes in NOD mice.
    Takahashi K, Satoh J, Sagara M, Zhu XP, Muto G, Muto Y, Fukuzawa M, Nishimura S, Miyaguchi S, Toyata T.
    J Autoimmun; 1995 Jun; 8(3):335-46. PubMed ID: 7575995
    [Abstract] [Full Text] [Related]

  • 2. Human LT-alpha-mediated resistance to autoimmune diabetes is induced in NOD, but not NOD-scid, mice and abrogated by IL-12.
    Miyaguchi S, Satoh J, Takahashi K, Sakata Y, Nakazawa T, Miyazaki J, Toyota T.
    Clin Immunol; 2001 Jan; 98(1):119-24. PubMed ID: 11141334
    [Abstract] [Full Text] [Related]

  • 3. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide.
    Qin HY, Singh B.
    J Autoimmun; 1997 Jun; 10(3):271-8. PubMed ID: 9218754
    [Abstract] [Full Text] [Related]

  • 4. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
    O'Brien BA, Harmon BV, Cameron DP, Allan DJ.
    J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724
    [Abstract] [Full Text] [Related]

  • 5. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice.
    Yasunami R, Bach JF.
    Eur J Immunol; 1988 Mar; 18(3):481-4. PubMed ID: 2965652
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFN-gamma secretion pathway.
    Ablamunits V, Quintana F, Reshef T, Elias D, Cohen IR.
    J Autoimmun; 1999 Dec; 13(4):383-92. PubMed ID: 10585754
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae.
    Saï P, Rivereau AS.
    Diabetes Metab; 1996 Oct; 22(5):341-8. PubMed ID: 8896996
    [Abstract] [Full Text] [Related]

  • 11. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
    Moritani M, Yoshimoto K, Wong SF, Tanaka C, Yamaoka T, Sano T, Komagata Y, Miyazaki J, Kikutani H, Itakura M.
    J Clin Invest; 1998 Aug 01; 102(3):499-506. PubMed ID: 9691086
    [Abstract] [Full Text] [Related]

  • 12. Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse.
    Maron R, Guerau-de-Arellano M, Zhang X, Weiner HL.
    J Autoimmun; 2001 Feb 01; 16(1):21-8. PubMed ID: 11221993
    [Abstract] [Full Text] [Related]

  • 13. TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes.
    Kägi D, Ho A, Odermatt B, Zakarian A, Ohashi PS, Mak TW.
    J Immunol; 1999 Apr 15; 162(8):4598-605. PubMed ID: 10201999
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of action of a streptococcal preparation (OK-432) in prevention of autoimmune diabetes in NOD mice. Suppression of generation of effector cells for pancreatic B cell destruction.
    Shintani S, Satoh J, Seino H, Goto Y, Toyota T.
    J Immunol; 1990 Jan 01; 144(1):136-41. PubMed ID: 2295787
    [Abstract] [Full Text] [Related]

  • 15. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
    Matsumoto M, Yagi H, Kunimoto K, Kawaguchi J, Makino S, Harada M.
    Cell Immunol; 1993 Apr 15; 148(1):189-97. PubMed ID: 8098666
    [Abstract] [Full Text] [Related]

  • 16. Novel leptin receptor mutation in NOD/LtJ mice suppresses type 1 diabetes progression: II. Immunologic analysis.
    Lee CH, Chen YG, Chen J, Reifsnyder PC, Serreze DV, Clare-Salzler M, Rodriguez M, Wasserfall C, Atkinson MA, Leiter EH.
    Diabetes; 2006 Jan 15; 55(1):171-8. PubMed ID: 16380490
    [Abstract] [Full Text] [Related]

  • 17. Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor.
    Nicoletti F, Di Marco R, Barcellini W, Magro G, Schorlemmer HU, Kurrle R, Lunetta M, Grasso S, Zaccone P, Meroni P.
    Eur J Immunol; 1994 Aug 15; 24(8):1843-7. PubMed ID: 8056041
    [Abstract] [Full Text] [Related]

  • 18. Differential impact of T cell repertoire diversity in diabetes-prone or -resistant IL-10 transgenic mice.
    Balasa B, Lee J, Sarvetnick N.
    Cell Immunol; 1999 May 01; 193(2):170-8. PubMed ID: 10222059
    [Abstract] [Full Text] [Related]

  • 19. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.
    Bergerot I, Fabien N, Thivolet C.
    Diabetes Metab; 1996 Jul 01; 22(4):235-9. PubMed ID: 8767168
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.